Loading
22nd Century Group, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 12 Sept 2024.
22nd Century Group, Inc.: what insiders have been doing
22nd Century Group, Inc., classified in the Food & Agriculture sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 18 October 2026, 8 filings were filed, from 8 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of 22nd Century Group, Inc. has been absent for the past year. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction.
Compared with its exchange (5,816 companies, median 19 filings), a count of 8 filings is below the norm. Our records for 22nd Century Group, Inc. go back to 2016, with 5 purchases and 4 sales on the open market in total. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 17.6 m USD and net income at -5.1 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Village Farms International, Inc. and Orkla ASA. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
60
Thresholds
n/a
Buy Volume
€100,147
5 ops. · all time
Sell Volume
€1M
4 ops. · all time
Since the insiders bought
- -99.8%Entry US$318,573.00 · Close at T+365 US$516.00
- -98.0%Entry US$2,742,336.00 · Close at T+365 US$55,890.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$4.11
Analyst consensus
Income statement
RevenueUS$7M
Gross profit-US$3.1M-45% margin
EBITDA-US$10.5M-149% margin
Net income-US$5.1M-65.8% margin
Valuation
PER (trailing)0.0x
P/Book0.1x
Beta0.60
Balance sheet & cash
Market capUS$1.4M
Total debtUS$1.5M
Free Cash Flow-US$8.6M
Debt / Equity6%
Profitability & ownership
ROE-103.5%
ROA-28.3%
% insiders0.0%
% institutions10.3%
Last declaration on 14 November 2025
Declarations60 total
17,295 shares0Common StockSEC:0000897069-25-001707:0
37,146 shares0Common StockSEC:0000897069-25-001693:0
11,006 shares0Common StockSEC:0000897069-25-001689:0
37,146 shares0Common StockSEC:0000897069-25-001687:0
66,824 shares0Common StockSEC:0000897069-25-001685:0
12,578 shares0Common StockSEC:0000897069-25-001683:0
32,429 shares0Common StockSEC:0000897069-25-001695:0
32,429 shares0Common StockSEC:0000897069-25-001691:0
2,118 shares0Common StockSEC:0000897069-25-001566:0
14,565 shares0Common StockSEC:0000897069-25-000582:0
4,237 shares0Common StockSEC:0000897069-25-000586:0
2,472 shares0Common StockSEC:0000897069-25-000589:0
30,014 shares0Common StockSEC:0000897069-25-000584:0
16,684 shares0Common StockSEC:0000897069-25-000578:0
16,684 shares0Common StockSEC:0000897069-25-000580:0
2,472 shares0Common StockSEC:0000897069-25-000591:0
14,565 shares0Common StockSEC:0000897069-25-000576:0
39,000 shares@ US$0.268427.5% of flowCommon StockSEC:0001104659-24-099370:0
Canonical exit: 11 Dec 2024 (T+90)
9,000 shares@ US$1.092126.4% of flowCommon StockSEC:0001104659-24-067136:0
Canonical exit: 28 Aug 2024 (T+90)
100,000 shares@ US$0.1749100.0% of flowCommon StockSEC:0001104659-24-002361:0
Canonical exit: 4 Apr 2024 (T+90)
100,000 shares@ US$0.173646.2% of flowCommon StockSEC:0001104659-24-001826:0
Canonical exit: 3 Apr 2024 (T+90)
21,210 shares@ US$0.871910.8% of flowCommon StockSEC:0001140361-23-012877:0
14,244 shares@ US$0.87247.2% of flowCommon StockSEC:0001140361-23-012877:1
54,735 shares@ US$0.87198.5% of flowCommon StockSEC:0001140361-23-012878:0
225,841 shares@ US$0.872434.7% of flowCommon StockSEC:0001140361-23-012878:1
25 of 60 declarations
About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq: XXII) is a U.S.-listed company on the NYSE/NASDAQ market in the United States, with corporate headquarters in Mocksville, North Carolina. The company’s operating history traces back to 1998 through the predecessor entity that later evolved into today’s public company via a reverse-merger structure. In its most recent SEC filings and earnings releases, 22nd Century describes itself as a tobacco harm-reduction company focused on lowering nicotine exposure in combustible cigarettes, which makes it a highly specialized and differentiated player within the broader tobacco industry.
At present, the business is organized around a single reportable segment: tobacco. Its core offering is VLN®, a proprietary reduced-nicotine cigarette designed to provide adult smokers with a familiar combustible product while materially reducing nicotine intake. The company also sells partner-branded VLN products and provides contract manufacturing services for cigarettes and filtered cigars for third-party brands. This combination of proprietary products, licensing, and manufacturing gives 22nd Century a hybrid revenue model that blends brand development with industrial production.
Read moreShow less
From a competitive standpoint, 22nd Century is a niche small-cap company rather than a scale leader. It competes indirectly with the major tobacco groups, but its strategy is distinct: instead of emphasizing vaping, oral nicotine, or standard premium cigarettes, it focuses on reduced-nicotine combustible products. Its key competitive assets are its patented plant science, regulatory positioning, vertically integrated manufacturing, and the FDA authorization for a combustible modified-risk tobacco product. That FDA milestone remains central to the investment case because it supports the company’s commercial credibility and regulatory differentiation.
Recent developments have been centered on commercialization and distribution expansion. In 2025 and into 2026, the company reported broader retail rollout of VLN and partner VLN products, new state authorizations, and distribution agreements with convenience-store chains, wholesalers, and regional retail partners. Management also highlighted work on new product formats, including a 100 mm VLN initiative, intended to widen the addressable market and improve shelf penetration. These updates suggest the company is trying to shift from development-led execution toward broader commercialization.
Geographically, 22nd Century remains primarily U.S.-focused, with operations, manufacturing, and sales efforts centered in the United States. The company’s near-term opportunity is tied to expanding domestic distribution and converting regulatory approval into meaningful retail presence. However, it remains a high-risk, early-commercialization tobacco name, with execution, liquidity, and adoption risk still important for investors to monitor.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
